Is Pfizer a Millionaire Maker?
(NYSE: PFE) is a fairly well-known drugmaker, with a name that even non-healthcare-oriented types would likely know. That's a testament to the company's longevity and its success as a business. But the stock has fallen roughly 60% from its 2022 peak. Could stepping in to buy the downtrodden shares of Pfizer help turn you into a millionaire?
Pfizer is a drug company. That's a very complex line of work, with the company searching for and developing new drugs. It then has to test the drugs and get them approved by regulators. There are huge costs along the way, which is why drugmakers like Pfizer are allowed to have a time-limited right to be the exclusive producer of the new drugs they develop. The patents that protect the new drug, however, eventually run out.
Image source: Getty Images.
Source Fool.com
Pfizer Inc. Aktie
Leichte Buy-Präferenz bei der Pfizer Inc. Aktie.
Ein Kursziel von 27 € für Pfizer Inc. signalisiert eine potenzielle Steigerung von über 20% gegenüber dem aktuellen Kurs von 22.03 €.
